A nurse is reviewing the medical history of a client with acute renal failure. Which condition is a risk factor commonly associated with the development of acute renal failure?

A. Correct. Erythropoietin-stimulating agents (ESAs) are commonly used to treat anemia in clients with renal failure. These medications stimulate the production of red blood cells and help manage anemia associated with kidney dysfunction.

B. Incorrect. Anticoagulants such as heparin are not used to treat anemia; they are prescribed to prevent blood clotting and thrombosis.

C. Incorrect. Loop diuretics are used to promote diuresis and manage fluid overload in clients with acute renal failure; they do not treat anemia.

D. Incorrect. Antihypertensive agents are prescribed to manage hypertension and do not treat anemia in clients with renal failure.

QUESTIONS

A. Incorrect. Loop diuretics are used to increase urine output, not decrease it. They help reduce fluid overload and prevent dehydration.

B. Incorrect. Loop diuretics typically lead to a decrease in blood pressure, not an increase. They are often prescribed to address hypertension in acute renal failure.

C. Incorrect. Loop diuretics promote the excretion of sodium and water from the kidneys, not their reabsorption.

D. Correct. Loop diuretics are prescribed in acute renal failure to increase urine output and promote fluid excretion. This helps reduce fluid overload and decrease edema.